RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.86B
This Quarter Return
-8.89%
1 Year Return
+33.9%
3 Year Return
+119.1%
5 Year Return
+206.57%
10 Year Return
+613.71%
AUM
$2.51B
AUM Growth
+$2.51B
(-11%)
Cap. Flow
+$20.2M
Cap. Flow
% of AUM
0.81%
Top 10 Holdings %
Top 10 Hldgs %
23.56%
Holding
327
New
15
Increased
111
Reduced
164
Closed
21
Top Buys
| 1 |
Digital Turbine
APPS
|
$21.5M |
| 2 |
Neurocrine Biosciences
NBIX
|
$12.8M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$7.55M |
| 4 |
CHUY
Chuy's Holdings, Inc. Common Stock
CHUY
|
$6.21M |
| 5 |
GoDaddy
GDDY
|
$5.85M |
Top Sells
| 1 |
MIME
Mimecast Limited
MIME
|
$15.9M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$12.6M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$11.1M |
| 4 |
NPTN
NEOPHOTONICS CORP
NPTN
|
$6.51M |
| 5 |
Collegium Pharmaceutical
COLL
|
$5.44M |
Sector Composition
| 1 | Technology | 29.22% |
| 2 | Healthcare | 23.72% |
| 3 | Industrials | 14.58% |
| 4 | Consumer Discretionary | 12.89% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.57M | 0.06% |
4,434
-50
| -1% | -$17.6K |
|
227
Coda Octopus Group
CODA
$91.1M
| $1.54M | 0.06% |
234,515
+7,289
| +3% | +$47.9K |
|
|
CNVY
228
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $1.52M | 0.06% |
232,615
+2,700
| +1% | +$17.7K |
|
229
OptimizeRx
OPRX
$326M
| $1.51M | 0.06% |
40,063
+1,063
| +3% | +$40.1K |
|
230
Puma Biotechnology
PBYI
$258M
| $1.47M | 0.06% |
511,233
+19,951
| +4% | +$57.4K |
|
231
SoundThinking
SSTI
$151M
| $1.42M | 0.06% |
51,248
+1,583
| +3% | +$43.9K |
|
232
Glacier Bancorp
GBCI
$5.79B
| $1.35M | 0.05% |
+26,885
| New | +$1.35M |
|
233
Teledyne Technologies
TDY
$25.5B
| $1.21M | 0.05% |
2,556
-48
| -2% | -$22.7K |
|
234
Treehouse Foods
THS
$917M
| $1.2M | 0.05% |
37,271
-455
| -1% | -$14.7K |
|
235
Castle Biosciences
CSTL
$673M
| $1.17M | 0.05% |
26,151
+938
| +4% | +$42.1K |
|
236
Columbia Sportswear
COLM
$3.1B
| $1.16M | 0.05% |
12,808
-156
| -1% | -$14.1K |
|
237
Denny's
DENN
$230M
| $1.1M | 0.04% |
76,912
+2,485
| +3% | +$35.6K |
|
238
AbbVie
ABBV
$374B
| $1.08M | 0.04% |
6,677
-300
| -4% | -$48.6K |
|
239
Y-mAbs Therapeutics
YMAB
$390M
| $1.07M | 0.04% |
90,375
+5,980
| +7% | +$71.1K |
|
240
Apple
AAPL
$3.54T
| $1.07M | 0.04% |
6,100
-1,468
| -19% | -$256K |
|
|
NATI
241
DELISTED
National Instruments Corp
NATI
| $1.04M | 0.04% |
25,537
-487
| -2% | -$19.8K |
|
242
UroGen Pharma
URGN
$896M
| $941K | 0.04% |
107,990
+6,631
| +7% | +$57.8K |
|
243
Abbott
ABT
$230B
| $821K | 0.03% |
6,936
-680
| -9% | -$80.5K |
|
244
Smith-Midland
SMID
$215M
| $715K | 0.03% |
40,264
+4,205
| +12% | +$74.7K |
|
245
Chevron
CVX
$318B
| $692K | 0.03% |
4,251
-392
| -8% | -$63.8K |
|
246
Hasbro
HAS
$11.1B
| $676K | 0.03% |
8,246
-235
| -3% | -$19.3K |
|
247
Eli Lilly
LLY
$661B
| $656K | 0.03% |
2,290
-100
| -4% | -$28.6K |
|
248
Moody's
MCO
$89B
| $644K | 0.03% |
1,910
-386
| -17% | -$130K |
|
249
Scholar Rock
SRRK
$3.3B
| $599K | 0.02% |
46,508
+1,437
| +3% | +$18.5K |
|
250
Upland Software
UPLD
$78.3M
| $571K | 0.02% |
32,434
+1,001
| +3% | +$17.6K |
|